APA

Borg J., Phylactides M., Bartsakoulia M., Tafrali C., Lederer C., Felice A. E., Papachatzopoulou A., Kourakli A., Stavrou E. F., Christou S., Hou J., Karkabouna S., Lappa-Manakou C., Ozgur Z., van Ijcken W., von Lindern M., Grosveld F. G., Georgitsi M., Kleanthous M., Philipsen S. & Patrinos G. P. (20130321). KLF10 gene expression is associated with high fetal hemoglobin levels and with response to hydroxyurea treatment in β-hemoglobinopathy patients. : Pharmacogenomics.

Chicago

Borg Joseph, Phylactides Marios, Bartsakoulia Marina, Tafrali Christina, Lederer Carsten, Felice Alexander E, Papachatzopoulou Adamantia, Kourakli Alexandra, Stavrou Eleana F, Christou Soteroula, Hou Jun, Karkabouna Sophia, Lappa-Manakou Christina, Ozgur Zeliha, van Ijcken Wilfred, von Lindern Marieke, Grosveld Frank G, Georgitsi Marianthi, Kleanthous Marina, Philipsen Sjaak and Patrinos George P. 20130321. KLF10 gene expression is associated with high fetal hemoglobin levels and with response to hydroxyurea treatment in β-hemoglobinopathy patients. : Pharmacogenomics.

Harvard

Borg J., Phylactides M., Bartsakoulia M., Tafrali C., Lederer C., Felice A. E., Papachatzopoulou A., Kourakli A., Stavrou E. F., Christou S., Hou J., Karkabouna S., Lappa-Manakou C., Ozgur Z., van Ijcken W., von Lindern M., Grosveld F. G., Georgitsi M., Kleanthous M., Philipsen S. and Patrinos G. P. (20130321). KLF10 gene expression is associated with high fetal hemoglobin levels and with response to hydroxyurea treatment in β-hemoglobinopathy patients. : Pharmacogenomics.

MLA

Borg Joseph, Phylactides Marios, Bartsakoulia Marina, Tafrali Christina, Lederer Carsten, Felice Alexander E, Papachatzopoulou Adamantia, Kourakli Alexandra, Stavrou Eleana F, Christou Soteroula, Hou Jun, Karkabouna Sophia, Lappa-Manakou Christina, Ozgur Zeliha, van Ijcken Wilfred, von Lindern Marieke, Grosveld Frank G, Georgitsi Marianthi, Kleanthous Marina, Philipsen Sjaak and Patrinos George P. KLF10 gene expression is associated with high fetal hemoglobin levels and with response to hydroxyurea treatment in β-hemoglobinopathy patients. : Pharmacogenomics. 20130321.